↓ Skip to main content

Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia

Overview of attention for article published in BMC Psychiatry, February 2014
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia
Published in
BMC Psychiatry, February 2014
DOI 10.1186/1471-244x-14-53
Pubmed ID
Authors

George Awad, Mariam Hassan, Antony Loebel, Jay Hsu, Andrei Pikalov, Krithika Rajagopalan

Abstract

Patients with schizophrenia frequently switch between antipsychotics, underscoring the need to achieve and maintain important treatment outcomes such as health-related quality of life (HRQoL) following the switch. This analysis evaluated HRQoL changes among patients with schizophrenia switched from their current antipsychotic to lurasidone.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 1%
Unknown 97 99%

Demographic breakdown

Readers by professional status Count As %
Other 13 13%
Researcher 11 11%
Student > Ph. D. Student 10 10%
Student > Bachelor 7 7%
Student > Master 6 6%
Other 17 17%
Unknown 34 35%
Readers by discipline Count As %
Medicine and Dentistry 21 21%
Pharmacology, Toxicology and Pharmaceutical Science 9 9%
Psychology 9 9%
Nursing and Health Professions 5 5%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 9 9%
Unknown 41 42%